bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
3.290
-0.210 (-6.00%)
At close: May 12, 2025, 4:00 PM
3.420
+0.130 (3.95%)
After-hours: May 12, 2025, 7:26 PM EDT
bluebird bio Market Cap
bluebird bio has a market cap or net worth of $32.21 million as of May 12, 2025. Its market cap has decreased by -68.08% in one year.
Market Cap
32.21M
Enterprise Value
340.43M
1-Year Change
-68.08%
Ranking
Category
Stock Price
$3.29
Market Cap Chart
Since June 19, 2013, bluebird bio's market cap has decreased from $588.50M to $32.21M, a decrease of -94.53%. That is a compound annual growth rate of -21.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 34.30M | -57.71% |
| Dec 31, 2024 | 81.10M | -46.26% |
| Dec 29, 2023 | 150.90M | -73.70% |
| Dec 30, 2022 | 573.70M | -18.09% |
| Dec 31, 2021 | 700.40M | -75.61% |
| Dec 31, 2020 | 2.87B | -40.85% |
| Dec 31, 2019 | 4.86B | -10.51% |
| Dec 31, 2018 | 5.43B | -33.53% |
| Dec 29, 2017 | 8.16B | 254.64% |
| Dec 30, 2016 | 2.30B | -2.28% |
| Dec 31, 2015 | 2.36B | -10.90% |
| Dec 31, 2014 | 2.64B | 429.89% |
| Dec 31, 2013 | 498.90M | -15.23% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |